Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Ghio

Showing results (61-70 of 264) with videos related to

Pageof 27
Sort By:
Drugs - Real World Outcomes|October 17, 2025
Economic and Social Burden of Pulmonary Arterial Hypertension in Italy: A Cost-of-Illness StudyMartina Paoletti, Dario Vizza, Michele D'Alto, et al.
European Heart Journal|May 4, 2013
Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) studyCecilia Linde, Michael R Gold, William T Abraham, et al.
Pulmonary Circulation|December 13, 2021
BMPR2 mutations and response to inhaled or parenteral prostanoids: a case seriesLaura Scelsi, Alessandra Greco, Mauro Acquaro, et al.
European Journal of Heart Failure|October 1, 2009
Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonanceStefano Ghio, Miriam Revera, Francesca Mori, et al.
Journal of the American College of Cardiology|October 6, 2009
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trialClaude Daubert, Michael R Gold, William T Abraham, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 3, 2007
Reverse right ventricular remodeling after pulmonary endarterectomyAndrea M D'Armini, Giorgio Zanotti, Stefano Ghio, et al.
Medicine|September 30, 2016
Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patientsLorenzo Cavagna, Veronica Codullo, Stefano Ghio, et al.
Open Heart|May 14, 2016
Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapyStefano Ghio, Silvia Pica, Catherine Klersy, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|November 24, 2004
Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesionsLaura Scelsi, Stefano Ghio, Carlo Campana, et al.
JACC. Heart Failure|March 4, 2017
Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE TrialMartin St John Sutton, Cecilia Linde, Michael R Gold, et al.
Pageof 27

Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
Drugs - Real World Outcomes|October 17, 2025
Economic and Social Burden of Pulmonary Arterial Hypertension in Italy: A Cost-of-Illness StudyMartina Paoletti, Dario Vizza, Michele D'Alto, et al.
European Heart Journal|May 4, 2013
Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) studyCecilia Linde, Michael R Gold, William T Abraham, et al.
Pulmonary Circulation|December 13, 2021
BMPR2 mutations and response to inhaled or parenteral prostanoids: a case seriesLaura Scelsi, Alessandra Greco, Mauro Acquaro, et al.
European Journal of Heart Failure|October 1, 2009
Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonanceStefano Ghio, Miriam Revera, Francesca Mori, et al.
Journal of the American College of Cardiology|October 6, 2009
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trialClaude Daubert, Michael R Gold, William T Abraham, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 3, 2007
Reverse right ventricular remodeling after pulmonary endarterectomyAndrea M D'Armini, Giorgio Zanotti, Stefano Ghio, et al.
Medicine|September 30, 2016
Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patientsLorenzo Cavagna, Veronica Codullo, Stefano Ghio, et al.
Open Heart|May 14, 2016
Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapyStefano Ghio, Silvia Pica, Catherine Klersy, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|November 24, 2004
Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesionsLaura Scelsi, Stefano Ghio, Carlo Campana, et al.
JACC. Heart Failure|March 4, 2017
Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE TrialMartin St John Sutton, Cecilia Linde, Michael R Gold, et al.
Pageof 27